EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Crosstalk Between Gut Microbiota, Epigenome, and Neurotransmitters in Health and Disease

Shabnam Nohesara iD, Hamid Mostafavi Abdolmaleky iD, Sam Thiagalingam iD

Cells · 16.07.2026 · 15 (14) · 1280

DOI: 10.3390/cells15141280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.07.2026. Verfasst von Shabnam Nohesara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA. Hauptthemen laut MEDLINE: Neurotransmitter Agents, Gastrointestinal Microbiome, Epigenesis, Genetic, Epigenome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Beyond its established roles in digestion, immune regulation, and enteroendocrine signaling, the gut microbiota (GM) influences distant organs, particularly the brain, by producing or modulating the balance of neurotransmitters (NTs) and regulating their intestinal metabolism through epigenetic mechanisms, thereby shaping gut–brain communication. In this narrative review, first, we provide an overview of the major classes of NTs, such as serotonin, dopamine, GABA, glutamate, acetylcholine, epinephrine, and norepinephrine, and their functions in the body and brain. Second, we discuss the potential epigenetic mechanisms through which alterations in the levels and/or activity of NTs contribute to health and disease. Third, we explore the potential roles of the GM in the production of biologically active metabolites, such as short-chain fatty acids (SCFAs), and in the regulation of NT metabolism and function in health and disease through epigenetic mechanisms. We also highlight how GM-modulating therapies may improve disease outcomes by altering epigenetically mediated intestinal NT metabolism and availability, with downstream effects on NT activity in other organs. Finally, we discuss the current challenges and future directions for elucidating the interplay among the epigenome, the GM, and NTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotransmitter AgentsGastrointestinal MicrobiomeEpigenesis, GeneticEpigenomeHealthHumansAnimals

Stichwörter der Autor:innen

DNA methylationSCFAsepigeneticsgut microbiotaneurotransmitters

Substanzen

Neurotransmitter Agents

Autor:innen und Institutionen

  • Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
  • Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Department of Pathology & Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.

ORCID-Profile: Shabnam Nohesara, Hamid Mostafavi Abdolmaleky, Sam Thiagalingam

Zitieren

APA

Nohesara, S., Mostafavi Abdolmaleky, H., & Thiagalingam, S. (2026). Crosstalk Between Gut Microbiota, Epigenome, and Neurotransmitters in Health and Disease. Cells, 15(14), 1280. https://doi.org/10.3390/cells15141280

Vancouver

Nohesara S, Mostafavi Abdolmaleky H, Thiagalingam S. Crosstalk Between Gut Microbiota, Epigenome, and Neurotransmitters in Health and Disease. Cells. 2026;15(14):1280. doi:10.3390/cells15141280

BibTeX
@article{Nohesara2026,
  author = {Nohesara, Shabnam and Mostafavi Abdolmaleky, Hamid and Thiagalingam, Sam},
  title = {Crosstalk Between Gut Microbiota, Epigenome, and Neurotransmitters in Health and Disease},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {1280},
  doi = {10.3390/cells15141280}
}
Kostenlos starten →